DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
14.14
-0.41 (-2.82%)
At close: Aug 24, 2026, 4:00 PM EDT
14.74
+0.60 (4.24%)
Pre-market: Aug 25, 2026, 5:06 AM EDT
DBV Technologies Employees
DBV Technologies had 170 employees as of June 30, 2026. The number of employees increased by 61 or 55.96% compared to the same quarter last year.
Employees
170
Change
61
Growth
55.96%
Revenue / Employee
$29,624
Profits / Employee
-$1,034,982
Market Cap
841.82M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 170 | 61 | 55.96% | 170 | 0 |
| Mar 31, 2026 | 161 | 55 | 51.89% | 161 | 0 |
| Dec 31, 2025 | 126 | 16 | 14.55% | 125 | 1 |
| Sep 30, 2025 | 117 | 9 | 8.33% | 117 | 0 |
| Jun 30, 2025 | 109 | 3 | 2.83% | 109 | 0 |
| Mar 31, 2025 | 106 | 1 | 0.95% | 106 | 0 |
| Dec 31, 2024 | 110 | 5 | 4.76% | 109 | 1 |
| Sep 30, 2024 | 108 | 11 | 11.34% | 108 | 0 |
| Jun 30, 2024 | 106 | 18 | 20.45% | 106 | 0 |
| Mar 31, 2024 | 105 | 17 | 19.32% | 105 | 0 |
| Dec 31, 2023 | 105 | 19 | 22.09% | 104 | 1 |
| Sep 30, 2023 | 97 | 12 | 14.12% | 97 | 0 |
| Jun 30, 2023 | 88 | 1 | 1.15% | 88 | 0 |
| Mar 31, 2023 | 88 | 0 | - | 88 | 0 |
| Dec 31, 2022 | 86 | -6 | -6.52% | 85 | 1 |
| Sep 30, 2022 | 85 | -7 | -7.61% | 85 | 0 |
| Jun 30, 2022 | 87 | -10 | -10.31% | 87 | 0 |
| Mar 31, 2022 | 88 | -16 | -15.38% | 88 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pharming Group | 407 |
| 4D Molecular Therapeutics | 196 |
| Rigel Pharmaceuticals | 174 |
| Aura Biosciences | 113 |
| Theravance Biopharma | 90 |
| Silence Therapeutics | 88 |
| SpyGlass Pharma | 76 |
| Oculis Holding AG | 60 |
DBVT News
- 25 days ago - DBVT Plans $50M ADS Share Issuance Amid Unprofitable Growth Phase - GuruFocus
- 25 days ago - DBV Technologies S.A.: DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq - Finanz Nachrichten
- 25 days ago - DBV Technologies announces sale of $50M of ADSs through ATM program - TheFly
- 25 days ago - DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq - GlobeNewsWire
- 4 weeks ago - DelveInsight Business Research, LLP: Food Allergy Market on the Rise: 5 Emerging Therapies to Watch | DelveInsight - Finanz Nachrichten
- 5 weeks ago - DBVT Secures $150M Shelf Registration to Support Future Growth - GuruFocus
- 5 weeks ago - DBV Technologies S.A.: DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales - Finanz Nachrichten
- 5 weeks ago - DBV Technologies announces $150M at-the-market offering - TheFly